首页>
外国专利>
Indazol - 3 - carboxamidas and their use as inhibitors of the Wnt Signalling Pathway / B catenin
Indazol - 3 - carboxamidas and their use as inhibitors of the Wnt Signalling Pathway / B catenin
展开▼
机译:吲达唑-3-羧甲酰胺类及其作为Wnt信号通路 / B catenin抑制剂的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
Relates to compounds of formula (i), wherein: R1, R2 and R4 are independently h, alkyl halide, C1 - CN, - 9, and ocf3 - CF3, among others; R3 is carbociclilr6, arilr6, heterociclilr6, among others; R5 is - (alkyl C1 - ncarbociclilr7 - (9), C1 - 9 nheterociclilr7, alkyl (alkyl) - C1 - 9) narilr7, among other S; R6 is 1 - 5 substituents selected from h, alkyl halide, Amine C1 - 9,,Among others; R7 is 1 - 5 C1 alkyl substituents selected from h, - 9, - ocf3, - CN, - CF3, among others; n is 0 OR 1. It also relates to a Pharmaceutical composition. These compounds are useful for the treatment of cancer, Diabetic Retinopathy, rheumatoid arthritis, viral or fungal infection
展开▼
机译:与式(i)的化合物有关,其中:R1,R2和R4独立地是h,烷基卤,C1-CN,-9和ocf3-CF3,等等; R 3是卡波克西林6,阿里尔6,杂基奥林6等。 R5是-(烷基C1-ncarbociclil7-(9),C1-9nheociociclir7,烷基(烷基)-C1-9)萘啶7,以及其他S; R 6是1-5个选自h,烷基卤,胺C 1-9,以及其他的取代基; R7是选自h,-9,-ocf3,-CN,-CF3等的1-5个C1烷基取代基; n为0或1。它也涉及药物组合物。这些化合物可用于治疗癌症,糖尿病性视网膜病,类风湿性关节炎,病毒或真菌感染
展开▼